publication venue for
- Recognizing therapeutic failure. 2009
- Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.. 59. 2021
- Experimental Candida albicans osteomyelitis: Microbiologic, antigenic, histologic, and 18FDG-PET-CT imaging characteristics in a newly established rabbit model.. 57. 2019
- In vitro combination therapy with isavuconazole against Candida spp.. 55. 2017
- Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases.. 55. 2017
- Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.. 53. 2015
- Methylprednisolone impairs conidial phagocytosis but does not attenuate hyphal damage by neutrophils against Exserohilum rostratum.. 53. 2014
- Uncommon opportunistic yeast bloodstream infections from Qatar.. 52. 2014
- Galectin-3 plays an important role in protection against disseminated candidiasis.. 51. 2013
- Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.. 51. 2012
- High efficiency opsonin-independent phagocytosis of Candida parapsilosis by human neutrophils.. 48. 2010
- Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century. 2017
- Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan. 2016
- Diagnostic imaging of experimental invasive pulmonary aspergillosis. 2009
- Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs. 2008